Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 September 2006

Volume 194, Number 5
The Journal of Infectious Diseases 2006;194:552–560
0022-1899/2006/19405-0004$15.00
DOI: 10.1086/506365
MAJOR ARTICLE

Natural History of Viral Markers in Children Infected with Human T Lymphotropic Virus Type I in Jamaica

Elizabeth Margaret Maloney,1,5

Yoshihisa Yamano,2,6

Paul C. VanVeldhuisen,1,3

Takashi Sawada,7

Norma Kim,4

Beverley Cranston,8

Barrie Hanchard,8

Steven Jacobson,2 and

Michie Hisada1

1Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, and 2Neuroimmunology Branch, National Institute of Neurologic Diseases and Stroke, National Institutes of Health, Department of Health and Human Services, Bethesda, and 3EMMES Corporation and 4Research Triangle Institute, Rockville, Maryland; 5Viral Exanthems and Herpesvirus Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia; 6Kagoshima City Hospital, Kagoshima, and 7Department of Clinical Research and Development, Clinical Research Center, Eisai, Tokyo, Japan; 8University of the West Indies, Mona Kingston, Jamaica

Purpose.We conducted a longitudinal analysis of human T lymphotropic virus type I (HTLV‐I) viral markers in 28 Jamaican mothers and their children, who were monitored for a median of 6.2 years after the birth of the children.

Methods.The HTLV‐I provirus DNA load was measured using the Taqman system (PE Applied Biosystems). The HTLV‐I antibody titer was determined using the Vironstika HTLV‐I/II Microelisa System (Organon Teknika). The HTLV‐I Tax‐specific antibody titers were measured using an enzyme‐linked immunosorbent assay. Generalized estimating equations were used to describe the associations of exposure variables with sequentially measured levels of HTLV‐I viral markers in children.

Results.The HTLV‐I antibody titer increased significantly up to 1 year after infection, reaching equilibrium at a median titer of 1:7786. The prevalence of Tax‐specific antibody reached 80% at 2 years after infection. The provirus load increased up to 2 years after infection, reaching equilibrium at a median of 6695 copies/100,000 peripheral blood mononuclear cells. The increase in the provirus load was significant only among children with eczema, but not among children without eczema.

Conclusions.The provirus loads in children increased for an additional year after their antibody titers had stabilized, possibly as a result of the expansion of HTLV‐I–infected clones. This effect was significant only for children with eczema. Among HTLV‐I–infected children, eczema may be a cutaneous marker of the risk of HTLV‐I–associated diseases developing in adulthood.

Received 10 January 2006; accepted 20 April 2006; electronically published 28 July 2006.

Reprints or correspondence: Elizabeth M. Maloney, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS A‐15, Atlanta, GA 30333 ().

Cited by

Anil K. Chaturvedi, Marianna Wilson, Kolby A. Sanders-Lewis, Hormuzd A. Katki, Nicole Urquhart, Michael A. Walters, Wendell Miley, Beverly Cranston, Barrie Hanchard, and Michie Hisada. (2007) Hematologic and Biochemical Changes Associated with Human T Lymphotropic Virus Type 1 Infection in Jamaica: A Report from the Population-Based Blood Donors Study. Clinical Infectious Diseases 45:8, 975-982
Online publication date: 15-Oct-2007.
  • Financial support: Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, and National Cancer Institute (research contracts N01‐CP31006, N01‐CP33043‐21, N01‐CP‐40548, and N01‐CP‐21121).

    Potential conflicts of interest: none reported.

Close Popup